Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Drake

Showing results (21-30 of 243) with videos related to

Pageof 25
Sort By:
Bone|December 15, 2016
Hormonal and systemic regulation of sclerostinMatthew T Drake, Sundeep Khosla
Endocrinology and Metabolism Clinics of North America|August 11, 2012
Male osteoporosisMatthew T Drake, Sundeep Khosla
Current Treatment Options in Rheumatology|July 25, 2022
Pros and Cons of Skeletal Medications in the COVID-19 EraElena Tsourdi, Matthew T Drake
Endocrinology and Metabolism Clinics of North America|May 23, 2021
Update on Approved Osteoporosis Therapies Including Combination and Sequential Use of AgentsDominik Saul, Matthew T Drake
British Journal of Clinical Pharmacology|February 7, 2019
The skeletal impact of cancer therapiesLucia Bedatsova, Matthew T Drake
Current Osteoporosis Reports|January 3, 2012
Potential role for therapies targeting DKK1, LRP5, and serotonin in the treatment of osteoporosisWei Zhang, Matthew T Drake
HSS Journal : the Musculoskeletal Journal of Hospital for Special Surgery|May 22, 2026
Implications of GLP-1 RA Therapy on Skeletal Health and Orthopedics: A CommentaryMoshe Gertzulin, Matthew T Drake
JBMR Plus|August 6, 2025
Bone anabolic therapy in breast cancer: is there a role for parathyroid hormone or parathyroid hormone-related protein?Hanna Taipaleenmäki, Matthew T Drake
Bone|February 17, 2022
Editorial - Cancer and Bone special issueClaire M Edwards, Matthew T Drake
Mayo Clinic Proceedings|September 6, 2016
Optimizing Insulin Delivery in Patients With Diabetes Mellitus: Still Room for ImprovementMatthew T Drake, Steven A Smith
Pageof 25

Showing results (21-30 of 243) with videos related to

Sort By:
Pageof 25
Bone|December 15, 2016
Hormonal and systemic regulation of sclerostinMatthew T Drake, Sundeep Khosla
Endocrinology and Metabolism Clinics of North America|August 11, 2012
Male osteoporosisMatthew T Drake, Sundeep Khosla
Current Treatment Options in Rheumatology|July 25, 2022
Pros and Cons of Skeletal Medications in the COVID-19 EraElena Tsourdi, Matthew T Drake
Endocrinology and Metabolism Clinics of North America|May 23, 2021
Update on Approved Osteoporosis Therapies Including Combination and Sequential Use of AgentsDominik Saul, Matthew T Drake
British Journal of Clinical Pharmacology|February 7, 2019
The skeletal impact of cancer therapiesLucia Bedatsova, Matthew T Drake
Current Osteoporosis Reports|January 3, 2012
Potential role for therapies targeting DKK1, LRP5, and serotonin in the treatment of osteoporosisWei Zhang, Matthew T Drake
HSS Journal : the Musculoskeletal Journal of Hospital for Special Surgery|May 22, 2026
Implications of GLP-1 RA Therapy on Skeletal Health and Orthopedics: A CommentaryMoshe Gertzulin, Matthew T Drake
JBMR Plus|August 6, 2025
Bone anabolic therapy in breast cancer: is there a role for parathyroid hormone or parathyroid hormone-related protein?Hanna Taipaleenmäki, Matthew T Drake
Bone|February 17, 2022
Editorial - Cancer and Bone special issueClaire M Edwards, Matthew T Drake
Mayo Clinic Proceedings|September 6, 2016
Optimizing Insulin Delivery in Patients With Diabetes Mellitus: Still Room for ImprovementMatthew T Drake, Steven A Smith
Pageof 25